Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Modest, V. E.
Right arrow Articles by Butterworth, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Modest, V. E.
Right arrow Articles by Butterworth, J. F., IV
(Chest. 1995;108:1373-1379.)
© 1995 American College of Chest Physicians

Effect of pH and Lidocaine on β-Adrenergic Receptor Binding

Interaction During Resuscitation?

Vicki E. Modest MD1 and John F. Butterworth IV MD1

1 From the Department of Anesthesia, The Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC.

Epinephrine and other β-adrenergic receptor (βAR) agonists are often administered during cardiopulmonary resuscitation, a time when acid-base abnormalities and arrhythmias also commonly occur. We tested whether β2AR binding is influenced by pH or the antiarrhythmic drug lidocaine, and whether pH might influence the interaction of lidocaine with β2ARs. With institutional review board approval and informed consent, 32 venous blood samples were obtained from volunteers. Lymphocytes (which bear β2ARS similar to those found in heart) were isolated by density gradient centrifugation. Specific binding of the βAR ligand 3H-dihydroalprenolol (3H-DHA) was determined with lidocaine concentrations ranging from 10minus6 to 10minus2 mol/L (n=18 experiments), and with and without lidocaine (n=10 experiments), 100 µmol/L, and with and without QX314 (a permanently charged lidocaine derivative), 1 mmol/L (n=4 experiments). Data are presented as percent of control-specific binding measured at a pH of 7.4. Statistical analysis consisted of Spearman's rank-test. 3H-DHA-specific binding increased (p<.001) with pH. Thus, alkaline conditions favored binding of 3H-DHA to the receptor. Lidocaine inhibited 3H-DHA binding to β2ARs in a concentration-dependent manner. The concentration that inhibited specific binding of 3H-DHA by 50% was 3.1x10minus4 mol/L (95% confidence limits, 1.3x10minus4 to 7.5x10minus4 mol/L). Lidocaine potency at inhibiting β2AR binding also increased with increasing pH; thus, there was limited benefit (in terms of increasing binding to β2ARs) to increasing pH when lidocaine was present. QX314, despite being present in a 10-fold greater concentration than lidocaine, had no effect on 3H-DHA binding at any tested pH. The affinity of β2ARs for both 3H-DHA and lidocaine increased with pH. Thus, the response to β2AR agonists (when no lidocaine is present) might be expected to be greater with normal or alkalotic pH than under acidotic conditions, supporting the correction of metabolic acidosis to achieve optimal effects from β2AR agonists during resuscitation.

Key Words: acidosis • alkalosis • anesthetic • local • lidocaine • β-adrenergic receptors • receptor binding




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Bradley, J. M. Simsic, and D. M. Mulvihill
Hypoventilation improves oxygenation after bidirectional superior cavopulmonary connection
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1033 - 1039.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Chest Physicians.